THU-245 Safety, tolerability, pharmacokinetics, and pharmacodynamics of RO7565020, a novel monoclonal antibody that targets the hepatitis B surface antigen: results from a phase 1 single ascending dose study in healthy volunteers and participants with chronic hepatitis B
Man-Fung Yuen, Yan Huang, Qiudi Jiang, Andrea O. Y. Luk et autres